Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

0.6966 -0.0034 (-0.49%)
Streaming Delayed Price Updated: 2:49 PM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,314,827
Open 0.7100
Bid (Size) 0.6966 (700)
Ask (Size) 0.6967 (400)
Prev. Close 0.7000
Today's Range 0.6700 - 0.7119
52wk Range 0.5261 - 2.550
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Humacyte (HUMA) Q2 2026 Earnings Call Transcript ↗
Phase III trial shows 91 more catheter-free days for dialysis patients. 
Via The Motley Fool
Topics Earnings
News headline image
Humacyte Q2 Earnings Call Highlights ↗
Humacyte (NASDAQ:HUMA) reported second-quarter commercial sales growth while outlining plans to expand adoption of its SYMVESS vascular repair product, submit a supplemental biologics license... 
Via MarketBeat
Topics Earnings

Performance

YTD
-28.6%
-28.6%
1 Month
+3.3%
+3.3%
3 Month
-37.2%
-37.2%
6 Month
-37.8%
-37.8%
1 Year
-53.6%
-53.6%

More News

Read More
News headline image
Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA
From Kahn Swick & Foti, LLC
Via Business Wire
Humacyte Inc (NASDAQ:HUMA) Reports Q4 Revenue Miss, Shares Drop Pre-Market ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
MultiBagger MicroCaps IGC, RCT, PBK, HUMA, PRSO Stocks to Watch Now
Via AB Newswire
Topics Artificial Intelligence
MissionIRNewsBreaks – Humacyte Inc. (NASDAQ: HUMA) Prices $50 Million Public Offering
Via Investor Brand Network
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
Via Chartmill
News headline image
Humacyte (HUMA) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Humacyte (HUMA) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
Humacyte Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA
From Kahn Swick & Foti, LLC
Via Business Wire
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
News headline image
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
Via Stocktwits
News headline image
Humacyte (HUMA) Q3 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Death Earnings
News headline image
Humacyte Inc (NASDAQ:HUMA) Beats on EPS but Misses on Revenue in Q3 ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Insights Ahead: Humacyte's Quarterly Earnings ↗
Via Benzinga
BioMedNewsBreaks — Humacyte, Inc. (NASDAQ: HUMA) Announces $60 Million Registered Direct Offering of Common Stock and Warrants
Via Investor Brand Network
News headline image
D. Boral Capital Acted as Exclusive Placement Agent to Humacyte (Nasdaq: HUMA) in Connection with its $60,000,000 Registered Direct Offering
Via ACCESS Newswire
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga

Frequently Asked Questions

Is Humacyte, Inc. - Common Stock publicly traded?
Yes, Humacyte, Inc. - Common Stock is publicly traded.
What exchange does Humacyte, Inc. - Common Stock trade on?
Humacyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Humacyte, Inc. - Common Stock?
The ticker symbol for Humacyte, Inc. - Common Stock is HUMA on the Nasdaq Stock Market
What is the current price of Humacyte, Inc. - Common Stock?
The current price of Humacyte, Inc. - Common Stock is 0.6966
When was Humacyte, Inc. - Common Stock last traded?
The last trade of Humacyte, Inc. - Common Stock was at 08/26/26 02:49 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.